In 2025, made or projected biopharma workforce cuts affected about 42,700 employees, according to BioSpace tallies. BioSpace ...
Renaissance IPO ETF (IPO) is rated a buy, anticipating a surge in major IPOs through 2026 to fuel renewed investor interest.
As a SpaceX IPO approaches, potential investors in Elon Musk’s space technology company will need to learn something that ...
Clearing the air on whether Kotak Investment Bank has slipped on its fee growth in CY25 or is undercutting fee, its senior ...
Aniruddha Sarkar, CIO and Portfolio Manager Quest investment Advisors believes that Indian equities will outperform global markets in 2026 and suggests selective aggression for investors.
After a sluggish 2025, corporate earnings in India are poised for a rebound in this new year, with the trend likely to be driven by government reforms and tax cuts, according to a top strategist at ...